Citius Oncology (CTOR) Interest Expenses (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Interest Expenses of $6.9 million for Q1 2026, up 22559.54% year-over-year from N/an in Q1 2025, and down 79.31% quarter-over-quarter from $33.3 million in Q4 2025.
Citius Oncology (CTOR) Interest Expenses (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Interest Expenses for 4 consecutive years, with $6.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 22559.54% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (up 3137.11% YoY), while the FY2025 annual figure was $5.4 million, down 54.11% from the prior year.
- Interest Expenses retreated to $6.9 million in Q1 2026 per CTOR's latest filing, from $33.3 million in the prior quarter.
- Across five years, Interest Expenses topped out at $46.1 million in Q2 2025 and bottomed at $30368.0 in Q4 2023.
- Historically, Interest Expenses has averaged $9.3 million across 4 years, with a median of $470000.0 in 2024.
- On a YoY basis, Interest Expenses climbed as much as 50449.01% in 2025 and fell as far as 98.88% in 2025.
- Citius Oncology's Interest Expenses stood at $30368.0 in 2023, then soared by 1447.68% to $470000.0 in 2024, then jumped by 6976.46% to $33.3 million in 2025, then sank by 79.31% to $6.9 million in 2026.
- Business Quant data shows CTOR's Interest Expenses at $6.9 million in Q1 2026, $33.3 million in Q4 2025, and $131786.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -400.56 Mn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 2.90 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 120.70 Mn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 2.90 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 59.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Citius Oncology | 80.17 Mn | 80.17 Mn | 1.00 Mn | 231,732.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.88 Mn |
| Mar 31, 2026 | 6.88 Mn |
| Dec 31, 2025 | 33.26 Mn |
| Dec 31, 2025 | 33.26 Mn |
| Sep 30, 2025 | 131,786.00 |
| Sep 30, 2025 | 131,786.00 |
| Jun 30, 2025 | 46.05 Mn |
| Jun 30, 2025 | 46.05 Mn |
| Mar 31, 2025 | 30,368.00 |
| Mar 31, 2025 | 30,368.00 |
| Dec 31, 2024 | 470,000.00 |
| Dec 31, 2024 | 470,000.00 |
| Sep 30, 2024 | 11.74 Mn |
| Sep 30, 2024 | 11.74 Mn |
| Jun 30, 2024 | 91,103.00 |
| Jun 30, 2024 | 91,103.00 |
| Mar 31, 2024 | 60,735.00 |
| Mar 31, 2024 | 60,735.00 |
| Dec 31, 2023 | 30,368.00 |
| Dec 31, 2023 | 30,368.00 |